Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas.-Reference-Cited by-同舟云学术

Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:e15196-e15196
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

De Celis Ferrari Anezka Carvalho Rubin¹,Pfiffer Tulio Eduardo Flesch²,Alex Alexandra Khichfy³,Nebuloni Daniela R.³,Carneiro Allyne Q.³,Capareli Fernanda Cunha⁴,Leite Luiz Antonio Senna³,Braghiroli Maria Ignez Freitas Melro⁵,Lobo Juliana³,Hoff Paulo Marcelo³,Riechelmann Rachel Pimenta³

Affiliation:

1. Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil

2. Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, Sao Paulo, Brazil

3. Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil

4. Instituto do Câncer do Estado de São Paulo, Sao Paulo, Brazil

5. Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.e15196

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review;Recent Patents on Anti-Cancer Drug Discovery;2021-05

2. MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells;Cell Metabolism;2015-10

3. Concise Review: Stem Cells in Pancreatic Cancer: From Concept to Translation;Stem Cells;2015-08-14